Cargando…

Macrophages as determinants and regulators of fibrosis in systemic sclerosis

SSc is a multiphase autoimmune disease with a well-known triad of clinical manifestations including vasculopathy, inflammation and fibrosis. Although a plethora of drugs has been suggested as potential candidates to halt SSc progression, nothing has proven clinically efficient. In SSc, both innate a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Al-Adwi, Yehya, Westra, Johanna, van Goor, Harry, Burgess, Janette K, Denton, Christopher P, Mulder, Douwe J
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2022
Materias:	Reviews
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9891414/ https://www.ncbi.nlm.nih.gov/pubmed/35861385 http://dx.doi.org/10.1093/rheumatology/keac410

Ejemplares similares

The soluble receptor for advanced glycation end products is potentially predictive of pulmonary arterial hypertension in systemic sclerosis
por: Atzeni, Isabella M., et al.
Publicado: (2023)

Release of High-Mobility Group Box-1 after a Raynaud’s Attack Leads to Fibroblast Activation and Interferon-γ Induced Protein-10 Production: Role in Systemic Sclerosis Pathogenesis
por: Al-Adwi, Yehya, et al.
Publicado: (2023)

Self-Reported Systemic Sclerosis-Related Symptoms Are More Prevalent in Subjects with Raynaud’s Phenomenon in the Lifelines Population: Focus on Pulmonary Complications
por: van de Zande, Saskia Corine, et al.
Publicado: (2023)

Hydrogen Sulfide: A Therapeutic Option in Systemic Sclerosis
por: Abdulle, Amaal Eman, et al.
Publicado: (2018)

Correction: Abdulle, A.E., et al. Hydrogen Sulfide: A Therapeutic Option in Systemic Sclerosis. Int. J. Mol. Sci. 2018, 19, 4121
por: Abdulle, Amaal Eman, et al.
Publicado: (2019)

The Role of Oxidative Stress in the Development of Systemic Sclerosis Related Vasculopathy
por: Abdulle, Amaal E., et al.
Publicado: (2018)

Macrophage–stroma interactions in fibrosis: biochemical, biophysical, and cellular perspectives
por: Vasse, Gwenda F, et al.
Publicado: (2021)

Rapid free thiol rebound is a physiological response following cold‐induced vasoconstriction in healthy humans, primary Raynaud and systemic sclerosis
por: Abdulle, Amaal Eman, et al.
Publicado: (2019)

Therapeutic targets in systemic sclerosis
por: Denton, Christopher P
Publicado: (2007)

Stem cell enriched lipotransfer reverses the effects of fibrosis in systemic sclerosis
por: Almadori, Aurora, et al.
Publicado: (2019)

Is the Macrophage Phenotype Determinant for Fibrosis Development?
por: Lis-López, Lluis, et al.
Publicado: (2021)

Biomarkers of Oxidative Stress in Systemic Lupus Erythematosus Patients with Active Nephritis
por: Liu, Lu, et al.
Publicado: (2023)

Shared expression of phenotypic markers in systemic sclerosis indicates a convergence of pericytes and fibroblasts to a myofibroblast lineage in fibrosis
por: Rajkumar, Vineeth S, et al.
Publicado: (2005)

M2 macrophage polarization in systemic sclerosis fibrosis: pathogenic mechanisms and therapeutic effects
por: Hu, Mingyue, et al.
Publicado: (2023)

Changes in macrophage transcriptome associate with systemic sclerosis and mediate GSDMA contribution to disease risk
por: Moreno-Moral, Aida, et al.
Publicado: (2018)

Data on CUX1 isoforms in idiopathic pulmonary fibrosis lung and systemic sclerosis skin tissue sections
por: Ikeda, Tetsurou, et al.
Publicado: (2016)

Pathogenesis of systemic sclerosis associated interstitial lung disease
por: Nihtyanova, Svetlana I, et al.
Publicado: (2020)

Cause or effect? Interpreting emerging evidence for dysbiosis in systemic sclerosis
por: Denton, Christopher P., et al.
Publicado: (2019)

Lysyl oxidases regulate fibrillar collagen remodelling in idiopathic pulmonary fibrosis
por: Tjin, Gavin, et al.
Publicado: (2017)

Failed Degradation of JunB Contributes to Overproduction of Type I Collagen and Development of Dermal Fibrosis in Patients With Systemic Sclerosis
por: Ponticos, Markella, et al.
Publicado: (2015)

Transforming growth factor-β-induced CUX1 isoforms are associated with fibrosis in systemic sclerosis lung fibroblasts
por: Ikeda, Tetsurou, et al.
Publicado: (2016)

Methods of Assessing Nailfold Capillaroscopy Compared to Video Capillaroscopy in Patients with Systemic Sclerosis—A Critical Review of the Literature
por: Ma, Zechen, et al.
Publicado: (2023)

The Fibrosis Burden of Systemic Sclerosis
por: Keane, Michael P.
Publicado: (2019)

Feasibility study of stem-cell enriched autologous lipotransfer to treat oro-facial fibrosis in systemic sclerosis (Sys-Stem): Protocol for open-label randomised controlled trial
por: Jeon, Faith Hyun Kyung, et al.
Publicado: (2020)

ACSL4 inhibition prevents macrophage ferroptosis and alleviates fibrosis in bleomycin-induced systemic sclerosis model
por: Cao, Dianyu, et al.
Publicado: (2023)

Renal Disease and Systemic Sclerosis: an Update on Scleroderma Renal Crisis
por: Cole, Alice, et al.
Publicado: (2022)

Extent of fibrosis and lung function decline in patients with systemic sclerosis and interstitial lung disease: data from the SENSCIS trial
por: Denton, Christopher P, et al.
Publicado: (2022)

A novel multi-network approach reveals tissue-specific cellular modulators of fibrosis in systemic sclerosis
por: Taroni, Jaclyn N., et al.
Publicado: (2017)

Expression and regulation of HIF-1alpha in macrophages under inflammatory conditions; significant reduction of VEGF by CaMKII inhibitor
por: Westra, Johanna, et al.
Publicado: (2010)

Systemic Oxidative Stress Is Increased in Postmenopausal Women and Independently Associates with Homocysteine Levels
por: Bourgonje, Arno R., et al.
Publicado: (2020)

Skin involvement in early diffuse cutaneous systemic sclerosis: an unmet clinical need
por: Herrick, Ariane L., et al.
Publicado: (2022)

Baicalein alleviates fibrosis and inflammation in systemic sclerosis by regulating B-cell abnormalities
por: Peng, Bo, et al.
Publicado: (2023)

Correction: Lysyl oxidases regulate fibrillar collagen remodelling in idiopathic pulmonary fibrosis (doi: 10.1242/dmm.030114)
por: Tjin, Gavin, et al.
Publicado: (2017)

Novel mechanism of regulation of fibrosis in kidney tumor with tuberous sclerosis
por: Liang, Sitai, et al.
Publicado: (2013)

Phenotypes Determined by Cluster Analysis and Their Survival in the Prospective European Scleroderma Trials and Research Cohort of Patients With Systemic Sclerosis
por: Sobanski, Vincent, et al.
Publicado: (2019)

Systemic sclerosis and related connective tissue diseases: present and future
por: Rubin, Lewis J, et al.
Publicado: (2007)

Relapsing polychondritis in systemic sclerosis: A rare vasculitic mimic
por: Teles, Carolina, et al.
Publicado: (2023)

Angiogenic T cells are decreased in people with type 2 diabetes mellitus and recruited by the dipeptidyl peptidase‐4 inhibitor Linagliptin: A subanalysis from a randomized, placebo‐controlled trial (RELEASE study)
por: de Boer, Stefanie A., et al.
Publicado: (2020)

State-of-the-art evidence in the treatment of systemic sclerosis
por: Pope, Janet E., et al.
Publicado: (2023)

The pan-PPAR agonist lanifibranor reduces development of lung fibrosis and attenuates cardiorespiratory manifestations in a transgenic mouse model of systemic sclerosis
por: Derrett-Smith, Emma, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_vkc3uphjgt8enf20v55stkb6va